GSK Plc’s shingles vaccine was linked to a longer delay in dementia onset than a competing shot, a finding that suggests superior protective powers against one of the world’s most threatening conditions. People who received the Shingrix vaccine lived an average of 164 days longer without a dementia diagnosis than those who got Merck & Co.’s Zostavax, according to a study published Thursday in the Nature Medicine journal. The Merck vaccine was linked to lower dementia risk in a study last year. [time-brightcove not-tgx=”true”] More than 55 million people worldwide have dementia, the seventh leading cause of death among older people globally. While recently approved drugs like E
Hence then, the article about the shingles vaccine may help delay dementia was published today ( ) and is available onTime ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( The Shingles Vaccine May Help Delay Dementia )